parthenolide and B16 Melanoma

parthenolide has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, JH; Heon Seo, K; Im, SY; Jun Park, S; Kim, HA; Kim, KJ; Ko, HM; Lee, HK	1

Other Studies

1 other study(ies) available for parthenolide and B16 Melanoma

Article	Year
Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation. Cancer research, 2006, May-01, Volume: 66, Issue:9 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; bcl-X Protein; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Interactions; Etoposide; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; NF-kappa B; Platelet Activating Factor; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sesquiterpenes; Up-Regulation	2006

Article

Year

Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.

Cancer research, 2006, May-01, Volume: 66, Issue:9

Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; bcl-X Protein; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Interactions; Etoposide; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; NF-kappa B; Platelet Activating Factor; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sesquiterpenes; Up-Regulation

2006